Les donnes compltes de cette tude seront publies en novembre, lors du congrs de lAmerican Heart Association
Prior authorization is handled internally (no third-party insurer to fight with), which sounds great until you realize Kaiser is both the gatekeeper and the gate
Orforglipron treatment also improved several cardiometabolic measures, including waist circumference, systolic blood pressure, and fasting lipid levels

Retatrutide is a new treatment for those who are overweight or living with obesity The medication has not yet received approval or become available It works by targeting three different receptors at the same time Clinical trials to date suggest potential weight loss of up to 24% Side effects seem to be similar to those seen with other GLP-1 medications About Retatrutide Retatrutide is a new treatment for those who are overweight or living with obesity The medication has not yet received approval or become available It works by targeting three different receptors at the same time Clinical trials to date suggest potential weight loss of up to 24% Side effects seem to be similar to those seen with other GLP-1 medications Retatrutide: new weight loss medication in development Retatrutide is a new medication that is currently attracting considerable attention as a potential treatment for overweight and obesity

Retatrutide may ultimately prove equal or superior, but we do not have that evidence yet
Appetite rebounds, often exceeding pre-treatment levels in the short term